Data from Japanese and American Pharmaceutical companies show how a new drug can significantly slow down cognitive decline in some patients, by 27 percent.
The 18-month trial involved nearly 2-thousand participants, who were in the early stages of the illness.
Dementia costs are more than a trillion dollars globally and early detection is crucial for recognising signs of Alzheimer’s or other cognitive decline.
So, what will be the impact of this new drug?
Presenter: Mohammed Jamjoom
Guests:
Graeme Sutherland – Son of Alzheimer’s sufferer & Social Media Ambassador for Alzheimer Scotland.
Bart De Strooper – Director of the UK Dementia Institute.
Susan Kohlhaas – Director of Research at Alzheimer’s Research UK.
– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/
@AljazeeraEnglish
#Aljazeeraenglish
#News
#InsideStory
#Alzheimer
#Japan
#UnitedStates
#US
Comments
Comments are disabled for this post.